NCT07192471 2026-04-20
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Phase 1 Not yet recruiting
Kyowa Kirin Co., Ltd.
Caja Costarricense de Seguro Social
Shanghai Jiao Tong University School of Medicine
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Boston Immune Technologies and Therapeutics
Fondazione Italiana Linfomi - ETS